Modur Vijay Insider Trades

Insider Trading History

Track insider trading activity for Modur Vijay. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Eloxx Pharmaceuticals
Eloxx Pharmaceuticals ELOX
HEAD OF R&d
Holding Value $45.3k 30,000 shares
Last Trade
Jan 25, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$128k 30,000 shares
$4.27
$1.51
Eloxx Pharmaceuticals
Eloxx Pharmaceuticals ELOX
HEAD OF R&d
Holding Value $331k 219,326 shares
Last Trade
Dec 01, 2021 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$6.33M 219,326 shares
$28.86
$1.51
Eloxx Pharmaceuticals
Eloxx Pharmaceuticals ELOX
HEAD OF R&d
Holding Value $234k 154,953 shares
Last Trade
Dec 01, 2021 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$1.86M 64,373 shares
$28.86
$1.51
Eloxx Pharmaceuticals
Eloxx Pharmaceuticals ELOX
HEAD OF R&d
Holding Value $0 0 shares
Last Trade
Dec 01, 2021 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$6.33M 219,326 shares
$28.86
$1.51
Eloxx Pharmaceuticals
Eloxx Pharmaceuticals ELOX
HEAD OF R&d
Holding Value $749k 496,204 shares
Last Trade
May 18, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$28M 496,204 shares
$56.40
$1.51
Eloxx Pharmaceuticals
Eloxx Pharmaceuticals ELOX
HEAD OF R&d
Holding Value $1.07M 711,619 shares
Last Trade
Apr 01, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$95.6M 711,619 shares
$134.40
$1.51

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up